EN
繁
简
About SSY Group
Company Profile
Chairman’s Statement
Directors and Senior Management
Corporate Video
Our Business
Major Products
Investor Relations
Announcements and Notices
Corporate Governance
Financial Reports
Presentations
Returns on Share Capital
Circulars
Shareholder Services
Corporate Information
News
Press Releases
Contact Us
IR and Media Contact
Announcements and Notices
Home
Investor Relations
Announcements and Notices
2022
Select Year
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Dec
28
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Dec
28
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN THE COMPOSITION OF BOARD COMMITTEES
Dec
28
Remuneration Committee Terms of Reference
Dec
20
NOTICE OF EXTRAORDINARY GENERAL MEETING
Dec
18
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
Dec
13
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
Nov
28
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
Nov
14
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Oct
28
(1) PROPOSED ADOPTION OF NEW SHARE OPTION SCHEME AND (2) SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSURES RELATING TO THE 2012 SHARE OPTION SCHEME
Oct
19
UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2022
Oct
10
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Sep
26
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Sep
13
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Sep
07
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Sep
05
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Aug
29
Interim Dividend for the six months ended 30 June 2022
Aug
29
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022
Aug
17
DATE OF BOARD MEETING
Aug
01
POSITIVE PROFIT ALERT
Jul
13
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT
Jul
06
QUOTATION OF JIANGSU BEST NEW MEDICAL ON THE NEEQ
Jul
04
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Jun
23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Jun
21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Jun
14
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
May
27
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
May
24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
May
23
AMENDED AND RESTATED ARTICLES OF ASSOCIATION
May
23
POLL RESULTS OF ANNUAL GENERAL MEETING 2022
May
16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
May
13
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Apr
28
APPROVAL OF QUOTATION OF JIANGSU BEST NEW MEDICAL ON THE NEEQ
Apr
19
Notice of Annual General Meeting
Apr
19
UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2022
Apr
06
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Mar
29
PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION
Mar
29
Final Dividend for the year ended 31 December 2021
Mar
29
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
Mar
18
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Mar
18
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Mar
17
DATE OF BOARD MEETING
Mar
09
DISCLOSEABLE TRANSACTION - ACQUISITION OF TARGET COMPANY
Mar
07
BUSINESS UPDATE - LETTER OF INTENT
Feb
09
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Jan
28
POSSIBLE SPIN-OFF AND SEPARATE QUOTATION OF JIANGSU BEST NEW MEDICAL ON THE NEEQ
Jan
11
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Jan
10
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Jan
06
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT